Do SGLT2 inhibitors reduce heart disease compared to DPP-4 inhibitors?

Posted by Medivizor on Jul 26, 2020 in Diabetes mellitus |

Email

In a nutshell

This study compared the effects on heart disease for SGLT2 inhibitors vs DPP-4 inhibitors in patients with type 2 diabetes (T2D). It found that patients using SGLT2 inhibitor medications had lower rates of heart failure, heart attack, and stroke.

Some background

T2D is a disorder of high levels of glucose (sugar) in the blood. T2D is connected to obesity and changes in…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *